📰 Genentech News
Page 27 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
February 25, 2024
The drug could become an important safety net for millions of people with food allergies.
February 25, 2024
Xolair cuts the risk of dangerous reactions after exposure to minute amounts of allergens, researchers reported. But children taking it still must avoid risky foods.
February 25, 2024
– Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year...
February 25, 2024
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat...
February 25, 2024
A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods.
February 25, 2024
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reaction The US FDA recently approved Xolair as the first and only medicine for children and adults with one or […]
February 25, 2024
Medication reduces potentially deadly reactions to allergy-triggering foods like nuts, milk and wheat.
February 25, 2024
(CNN) — A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those
February 25, 2024
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed...
February 23, 2024
Check out this week’s medical marketing news, people on the move and industry chatter.